InvestorsHub Logo
Followers 23
Posts 2187
Boards Moderated 0
Alias Born 03/18/2013

Re: caddiedad post# 405659

Monday, 03/13/2023 1:37:03 PM

Monday, March 13, 2023 1:37:03 PM

Post# of 425928
caddie; So far SGEN, PRVB have both been cash offers. You might be unto something.

M&A season is heating up. I'm not holding my breath thinking Amarin will be bought this M&A Season. Too many things to resolve, US market strategy, Europe reimbursements, getting Germany back to the negotiating table, Patent infringement case, Fraud on the court (forward looking). The latter is very intriguing (fraud). If that was achievable somehow, that would turn the tables for sure. Not counting the reshuffling of Amarin management. Who's going to be the next CEO, COB?

Has there been multiple acquisitions by one company (Big Pharma) in one year? $43B that's a substantial cash outlay. Of course Pfizer made bank on COVID, let's go shopping Mr. Borla.

Hmmm, PRVB only has one drug Tzield, yet it fetched $2.9B for its 90M shares. 260% increase.

SGEN has four medications in its pipeline. for a 15% increase in share price. 187M shares @ $43B
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News